当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:1287.47亿  总市值:1486.74亿
流通股本:25.01亿   总股本:28.88亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金29,359,129,012.7119,008,647,246.79,677,398,843.739,358,491,885.8
收到的税费返还1,312,328,095.051,065,061,541.52511,235,661.811,687,206,830.41
收到其他与经营活动有关的现金575,390,065.07499,205,927.07232,801,635.721,227,127,258.49
经营活动现金流入的平衡项目0000
经营活动现金流入小计31,246,847,172.8320,572,914,715.2910,421,436,141.2342,272,825,974.7
购买商品、接受劳务支付的现金10,928,215,498.327,091,223,065.853,405,483,457.6714,188,504,564.78
支付给职工以及为职工支付的现金8,183,330,993.395,831,344,419.113,298,434,673.6310,692,458,333.04
支付的各项税费2,369,175,464.681,937,492,949.89937,176,846.82,290,959,872.33
支付其他与经营活动有关的现金1,387,032,831.29746,560,093.07523,223,355.271,713,991,425.78
经营活动现金流出的平衡项目0000
经营活动现金流出小计22,867,754,787.6815,606,620,527.928,164,318,333.3728,885,914,195.93
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额8,379,092,385.154,966,294,187.372,257,117,807.8613,386,911,778.77
二、投资活动产生的现金流量:
收回投资收到的现金5,266,733,483.823,159,317,205.942,047,858,307.872,600,266,757.05
取得投资收益收到的现金242,713,508.52163,095,822.5141,393,123.65283,060,487.95
处置固定资产、无形资产和其他长期资产收回的现金净额9,734,408.389,444,507.71115,704.4816,118,970.91
投资活动现金流入的平衡项目0000
投资活动现金流入小计5,519,181,400.723,331,857,536.152,189,367,1362,899,446,215.91
购建固定资产、无形资产和其他长期资产支付的现金2,491,653,740.121,510,510,362.07810,766,081.095,516,558,842.19
投资支付的现金6,221,744,533.733,796,088,510.662,232,983,909.534,921,329,148.42
取得子公司及其他营业单位支付的现金---22,091,789.01
投资活动现金流出的平衡项目0000
投资活动现金流出小计8,713,398,273.855,306,598,872.733,043,749,990.6210,459,979,779.62
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-3,194,216,873.13-1,974,741,336.58-854,382,854.62-7,560,533,563.71
三、筹资活动产生的现金流量:
吸收投资收到的现金16,427,943.8816,427,943.888,682,084.96246,636,106.6
取得借款收到的现金8,265,727,336.785,559,410,201.232,920,640,979.016,843,975,150.94
筹资活动现金流入平衡项目0000
筹资活动现金流入小计8,282,155,280.665,575,838,145.112,929,323,063.977,090,611,257.54
偿还债务支付的现金6,957,913,214.434,197,452,235.421,546,633,303.626,665,760,526.12
分配股利、利润或偿付利息支付的现金3,049,740,937.382,641,006,578.5820,816,623.652,755,792,179.25
支付其他与筹资活动有关的现金4,179,385,606.752,199,067,483.461,405,168,115.941,610,442,236.9
筹资活动现金流出平衡项目0000
筹资活动现金流出小计14,187,039,758.569,037,526,297.462,972,618,043.2111,031,994,942.27
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-5,904,884,477.9-3,461,688,152.35-43,294,979.24-3,941,383,684.73
四、汇率变动对现金及现金等价物的影响-9,427,113.53168,611,655.79156,482,470.23132,139,998.6
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-729,436,079.41-301,523,645.771,515,922,444.232,017,134,528.93
加:期初现金及现金等价物余额10,001,038,812.0210,001,038,812.0210,001,038,812.027,983,904,283.09
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额9,271,602,732.619,699,515,166.2511,516,961,256.2510,001,038,812.02
补充资料:
净利润-4,280,845,682.91-9,700,260,033.27
资产减值准备--11,412,652.34-156,508,914.41
固定资产和投资性房地产折旧-1,064,715,480.54-1,901,596,119.09
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,064,715,480.54-1,901,596,119.09
无形资产摊销-83,896,869.39-157,861,503.22
长期待摊费用摊销-116,537,583.71-228,280,536.91
处置固定资产、无形资产和其他长期资产的损失-3,454,353.96-33,450,046.48
固定资产报废损失-2,635,505.76-11,778,692.16
公允价值变动损失-99,587,866.93-37,809,127.95
财务费用--419,747,401.91-13,223,055.73
投资损失--22,379,410.5--233,848,997.4
递延所得税--6,082,318.93-232,560,344.31
其中:递延所得税资产减少--72,874,884.19-142,915,760.76
递延所得税负债增加-66,792,565.26-89,644,583.55
存货的减少--530,209,668.91-977,626,158.3
经营性应收项目的减少-393,964,977.78--2,140,598,895.08
经营性应付项目的增加--513,977,092.32-1,058,302,166.39
其他-196,155,788.38-756,006,487.94
现金的期末余额-9,699,515,166.25-10,001,038,812.02
减:现金的期初余额-10,001,038,812.02-7,983,904,283.09
公告日期2024-10-292024-07-302024-04-302024-03-19
审计意见(境内)标准无保留意见
TOP↑